Palisades Hudson Asset Management’s Allergan Inc AGN Stock Holding History

Palisades Hudson Asset Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,938	Closed	-$412K	–	100
2014 Q4	$412K	Hold	1,938	–	–	0.32%	41
2014 Q3	$345K	Hold	1,938	–	–	0.28%	51
2014 Q2	$328K	Hold	1,938	–	–	0.27%	42
2014 Q1	$241K	Hold	1,938	–	–	0.21%	60
2013 Q4	$215K	Buy	+1,938	New	+$185K	0.18%	64

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Palisades Hudson Asset Management's AGN Position: Q1 2015 in Review

Palisades Hudson Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,938 shares — an estimated $412K sold.

Palisades Hudson Asset Management first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $412K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Palisades Hudson Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Palisades Hudson Asset Management sold 1,938 Allergan Inc shares in Q1 2015, an estimated $412K.
Palisades Hudson Asset Management first reported a position in Allergan Inc in Q4 2013 and held it in 5 quarters.
Palisades Hudson Asset Management's Allergan Inc position peaked at $412K in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Palisades Hudson Asset Management's 13F filing for Q1 2015, filed 13 May 2015.